LKQ Corporation to Present at Upcoming Investor Conferences
Nov 21, 2016 21:15 pm UTC| Business
CHICAGO, Nov. 21, 2016 -- LKQ Corporation (Nasdaq:LKQ) today announced that members of its senior management will be presenting at the following investor conferences: HSBC's High Yield Conference 2016November 22,...
James River Group Holdings Announces Secondary Offering
Nov 21, 2016 21:10 pm UTC| Business
PEMBROKE, Bermuda, Nov. 21, 2016 -- James River Group Holdings, Ltd. (NASDAQ:JRVR) (“James River” or the “Company”) announced today that certain of the Company’s significant shareholders intend to offer in an...
Bridge Bancorp, Inc. Announces Commencement of Common Stock Offering
Nov 21, 2016 21:05 pm UTC| Business
BRIDGEHAMPTON, N.Y., Nov. 21, 2016 -- Bridge Bancorp, Inc. (Nasdaq:BDGE), the parent company of The Bridgehampton National Bank, today announced it has commenced an underwritten public offering of approximately $50.0...
SPAR Group Announces Financial Results for the Third Quarter Ended September 30, 2016
Nov 21, 2016 21:05 pm UTC| Business
WHITE PLAINS, N.Y., Nov. 21, 2016 -- SPAR Group, Inc. (Nasdaq:SGRP), a leading supplier of retail merchandising and other marketing services throughout the United States and internationally, today announced financial...
Spectranetics Receives CE Mark for Stellarex™ 0.014” Drug-Coated Balloon
Nov 21, 2016 21:05 pm UTC| Business
COLORADO SPRINGS, Colo., Nov. 21, 2016 -- The Spectranetics Corporation (NASDAQ:SPNC) today announced that its Stellarex™ 0.014” Drug-coated Angioplasty Balloon (DCB) has received the CE mark. The Stellarex 0.014”...
Tesaro Announces Participation in Three Investor Conferences
Nov 21, 2016 21:05 pm UTC| Business
WALTHAM, Mass., Nov. 21, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are: The...
Corium Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Recent Corporate Highlights
Nov 21, 2016 21:02 pm UTC| Business
MENLO PARK, Calif., Nov. 21, 2016 -- Corium International,Inc.(Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...